Language

News topic

Active ingredient Ropivacaine Hydrochloride

Current shortage notices for the active ingredient Ropivacaine Hydrochloride, structured by product, country and reporting period.

7 notices

← All shortages

What the Ropivacaine Hydrochloride notices indicate for the supply chain

The 7 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Naropin 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 10 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 7.5 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Naropin 2 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. opl. epidur. 5 x 100 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inf. opl. epidur. 5 x 200 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →